API
< Back to all clusters
[HEALTH] · South Korea · 4 sources

started · updated

Severance Hospital study shows early combination therapy for cardiovascular disease

A large scale clinical study conducted by researchers at Yonsei University Severance Hospital suggests that using a combination of statins and ezetimibe from the start of treatment is more effective for patients with atherosclerotic cardiovascular disease than starting with statins alone.

The study, which involved 3,048 patients across 17 hospitals in South Korea between January 2021 and July 2022, was presented at the American Heart Association scientific session and published in the journal Circulation. Researchers found that the early combination therapy helped patients reach LDL cholesterol targets significantly faster and at higher rates.

In the group with an intensive target of less than 55 mg/dL, the combination therapy group achieved the goal at a rate of 44.3% after one month, compared to only 18.3% in the statin-only group. This trend continued over a three year follow up period. While the combination therapy was more effective at reaching targets, the study noted no significant difference in the incidence of major cardiovascular events or side effects between the two groups.

Entities

American Heart Association · Circulation · Kim Byung-geuk · Lee Sang-hyeop · Yonsei University Severance Hospital